Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07174596 · ClinicalTrials.gov registry record · NA
Evaluation of Approved Contact Lenses
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT07174596: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT07174596 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07174596, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, subject-masked, bilateral, dispensing, multi-site, 2 lenses × 3 wearing periods crossover study to evaluate visual acuity.
Primary Outcome
Visual acuity (VA) will be collected for each eye at distance using Snellen charts at the fitting evaluation and after approximately 1-week of lens wear.
Interventions
- DEVICE B+L Infuse spherical soft contact lenses
- DEVICE J&J ACUVUE OASYS 1-Day spherical soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2025-10-27 |
| Phase | NA |
What the finished NCT07174596 record still lists
NCT07174596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which B+L Infuse spherical soft contact lenses is the first listed.
NCT07174596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07174596 about?
NCT07174596 is a clinical study titled "Evaluation of Approved Contact Lenses". This is a prospective, randomized, controlled, subject-masked, bilateral, dispensing, multi-site, 2 lenses × 3 wearing periods crossover study to evaluate visual acuity.
What is the current status of trial NCT07174596?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2025-09-11. Estimated completion is 2025-10-27.
What interventions are being tested in trial NCT07174596?
The interventions under investigation include: B+L Infuse spherical soft contact lenses (DEVICE), J&J ACUVUE OASYS 1-Day spherical soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT07174596?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07174596's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI